scholarly journals Depression, social support, and clinical outcomes following lung transplantation: a single-center cohort study

2017 ◽  
Vol 31 (5) ◽  
pp. 495-502 ◽  
Author(s):  
Patrick J. Smith ◽  
Laurie D. Snyder ◽  
Scott M. Palmer ◽  
Benson M. Hoffman ◽  
Gregory L. Stonerock ◽  
...  
Keyword(s):  
Social Support ◽  
Cohort Study ◽  
Lung Transplantation ◽  
Clinical Outcomes ◽  
Single Center

scholarly journals Predictors and clinical outcomes of silent hypoxia in COVID-19 patients, a single-center retrospective cohort study

2021 ◽  
Vol 14 (11) ◽  
pp. 1595-1599
Author(s):  
Faisal Alhusain ◽  
Azam Alromaih ◽  
Ghassan Alhajress ◽  
Abdullah Alsaghyir ◽  
Ali Alqobaisi ◽  
...  
Keyword(s):  
Cohort Study ◽  
Clinical Outcomes ◽  
Retrospective Cohort Study ◽  
Retrospective Cohort ◽  
Single Center

scholarly journals Retrospective single center cohort study: effect of intensive home hemodialysis on right ventricular systolic pressure and clinical outcomes

2020 ◽  
Vol 21 (1) ◽  
Author(s):  
Michael Girsberger ◽  
Christopher T. Chan
Keyword(s):  
Cohort Study ◽  
Right Ventricular ◽  
Clinical Outcomes ◽  
Systolic Pressure ◽  
Composite Endpoint ◽  
Single Center ◽  
Right Ventricular Systolic Pressure ◽  
Home Hemodialysis ◽  
Ventricular Systolic Pressure

Abstract Background Increased right ventricular systolic pressure (RVSP), a surrogate marker for pulmonary hypertension, is common in patients with end-stage kidney disease. Limited data suggest improvement of RVSP with intensive dialysis, but it is unknown whether these improvements translate to better clinical outcomes. Methods We conducted a retrospective single center cohort study at the Toronto General Hospital. All patients who performed intensive home hemodialysis (IHHD) for at least a year between 1999 and 2017, and who had a baseline as well as a follow-up echocardiogram more than a year after IHHD, were included. Patients were categorized into two groups based on the RVSP at follow-up: elevated (≥ 35 mmHg) and normal RVSP. Multivariate and cox regression analyses were done to identify risk factors for elevated RVSP at follow-up and reaching the composite endpoint (death, cardiovascular hospitalization, treatment failure), respectively. Results One hundred eight patients were included in the study. At baseline, 63% (68/108) of patients had normal RVSP and 37% (40/108) having elevated RVSP. After a follow-up of 4 years, 70% (76/108) patient had normal RVSP while 30% (32/108) had elevated RVSP. 8 (10%) out of the 76 patients with normal RVSP and 15 (47%) out of the 32 patients with elevated RVSP reached the composite endpoint of death, cardiovascular hospitalization or technique failure. In a multivariate analysis, age, diabetes and smoking were not associated with elevated RVSP at follow-up. Elevated RVSP at baseline was not associated with a higher likelihood in reaching the composite endpoint or mortality. Conclusion Mean RVSP did not increase in patients on IHHD over time, and maintenance of normal RVSP was associated with better clinical outcomes.

Comparison of Oto, MALT and ET-Score in Predicting Outcome after Lung Transplantation - A Large Single-Center Cohort Study

2019 ◽  
Vol 38 (4) ◽  
pp. S421
Author(s):  
S. Schwarz ◽  
N. Rahimi ◽  
M. Muckenhuber ◽  
A. Benazzo ◽  
B. Moser ◽  
...  
Keyword(s):  
Cohort Study ◽  
Lung Transplantation ◽  
Single Center ◽  
Predicting Outcome

scholarly journals Clinical Outcomes of Heart-Lung Transplantation: Review of 10 Single-Center Consecutive Patients

2016 ◽  
Vol 49 (3) ◽  
pp. 157-164 ◽  
Author(s):  
Jae Kwang Yun ◽  
Se Hoon Choi ◽  
Seung-Il Park ◽  
Keyword(s):  
Lung Transplantation ◽  
Clinical Outcomes ◽  
Single Center

scholarly journals Current precautions and future directions in lung transplantation during the COVID‐19 pandemic – a single center cohort study

2020 ◽  
Vol 33 (11) ◽  
pp. 1453-1457 ◽  
Author(s):  
Norihisa Shigemura ◽  
Francis Cordova ◽  
Gerard Criner ◽  
Yoshiya Toyoda
Keyword(s):  
Cohort Study ◽  
Lung Transplantation ◽  
Single Center ◽  
Future Directions

scholarly journals Clinical Outcomes with Definitive Treatment of Methicillin-resistant Staphylococcus aureus (MRSA) Bacteremia with Retained Daptomycin and Ceftaroline Combination Therapy versus De-escalation to Monotherapy with Vancomycin, Daptomycin, or Ceftaroline

2021 ◽  
Author(s):  
Courtney N Nichols ◽  
Lynn C Wardlow ◽  
Kelci E Coe ◽  
Mohammad Mahdee E Sobhanie
Keyword(s):  
Staphylococcus Aureus ◽  
Cohort Study ◽  
Combination Therapy ◽  
Clinical Outcomes ◽  
Methicillin Resistant Staphylococcus Aureus ◽  
Definitive Treatment ◽  
Composite Outcome ◽  
Single Center ◽  
Methicillin Resistant ◽  
Related Mortality

Abstract This retrospective single-center cohort study compared retained daptomycin and ceftaroline combination therapy versus de-escalation to vancomycin, daptomycin or ceftaroline monotherapy for MRSA bacteremia. No difference was found in the composite outcome of 60-day bacteremia recurrence, readmission or inpatient infection-related mortality for patients retained on combination therapy versus those de-escalated to monotherapy.

Impact of Cold Ischemic Time on Airway Complications After Lung Transplantation: A Single-center Cohort Study

2019 ◽  
Vol 51 (9) ◽  
pp. 2981-2985 ◽  
Author(s):  
Paolo Mendogni ◽  
Sara Pieropan ◽  
Lorenzo Rosso ◽  
Davide Tosi ◽  
Rosaria Carrinola ◽  
...  
Keyword(s):  
Cohort Study ◽  
Lung Transplantation ◽  
Single Center ◽  
Ischemic Time ◽  
Cold Ischemic Time ◽  
Airway Complications

Eosinophils in transbronchial biopsies: a predictor of chronic lung allograft dysfunction and reduced survival after lung transplantation — a retrospective single‐center cohort study

2020 ◽  
Vol 34 (1) ◽  
pp. 62-75 ◽  
Author(s):  
David R. Darley ◽  
Jin Ma ◽  
Ella Huszti ◽  
Pierre Fiset ◽  
Liran Levy ◽  
...  
Keyword(s):  
Cohort Study ◽  
Lung Transplantation ◽  
Single Center ◽  
Chronic Lung Allograft Dysfunction ◽  
Allograft Dysfunction
Sign in / Sign up

Export Citation Format

Share Document